Team:USTC CHINA/Project/Results/FurthurWork

From 2013.igem.org

(Difference between revisions)
 
(15 intermediate revisions not shown)
Line 11: Line 11:
<div id="igemlogo"><a href="https://2013.igem.org/Main_Page" target="_blank"><img src="https://static.igem.org/mediawiki/2013/2/26/2013ustcigem_IGEM_basic_Logo.png" alt="igem home page" width="50" height="40" /></a></div>
<div id="igemlogo"><a href="https://2013.igem.org/Main_Page" target="_blank"><img src="https://static.igem.org/mediawiki/2013/2/26/2013ustcigem_IGEM_basic_Logo.png" alt="igem home page" width="50" height="40" /></a></div>
          
          
-
  <ul id="nav">
+
<ul id="nav">
         <li><a href="https://2013.igem.org/Team:USTC_CHINA">Home</a></li>
         <li><a href="https://2013.igem.org/Team:USTC_CHINA">Home</a></li>
         <li class="active"><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Overview">Project</a>
         <li class="active"><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Overview">Project</a>
Line 18: Line 18:
                 <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/ProjectDetails">Project Details</a></li>
                 <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/ProjectDetails">Project Details</a></li>
                 <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">Results</a></li>
                 <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">Results</a></li>
-
                 <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Parts">Parts</a></li>
+
                 <li><a href="https://2013.igem.org/Team:USTC_CHINA/Parts">Parts</a></li>
             </ul>
             </ul>
         </li>
         </li>
Line 29: Line 29:
         <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/">Modeling</a>
         <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/">Modeling</a>
               <ul class="subs">
               <ul class="subs">
-
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/ReporterSystem">Reporter System</a></li>
+
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/KillSwitch">Kill Switch</a></li>
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/B.SubtilisCulture">B.Subtilis Culture</a></li>
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/B.SubtilisCulture">B.Subtilis Culture</a></li>
-
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/MiceModeling">Mice Modeling</a></li>
+
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/DesignsofImmuneExperiments">Designs of Immune Experiments</a></li>
               </ul>
               </ul>
         </li>
         </li>
Line 40: Line 40:
               </ul>
               </ul>
         </li>
         </li>
-
         <li><a href="https://2013.igem.org/Team:USTC_CHINA/team2">Team</a>
+
         <li><a href="https://2013.igem.org/Team:USTC_CHINA/Team">Team</a>
               <ul class="subs">
               <ul class="subs">
-
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/team2">Members</a></li>
+
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/Team">Members</a></li>
                   <li><a href="https://igem.org/Team.cgi?year=2013&team_name=USTC_CHINA">Profile</a></li>
                   <li><a href="https://igem.org/Team.cgi?year=2013&team_name=USTC_CHINA">Profile</a></li>
-
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/Team/Attribution">Attribution</a></li>
+
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/Attributions">Attributions</a></li>
-
                   <li><a href="https://2013.igem.org/Team:USTC_CHINA/Team/JudgingForm">Judging Form</a></li>
+
                   <li><a href="https://igem.org/2013_Judging_Form?id=1074#iGEM_Medals">Achievements</a></li>
               </ul>
               </ul>
         </li>
         </li>
         <li><a href="https://2013.igem.org/Team:USTC_CHINA/Safety">Safety</a></li>
         <li><a href="https://2013.igem.org/Team:USTC_CHINA/Safety">Safety</a></li>
-
</ul>
+
    </ul>
         <div id="tlogo"><img src="https://static.igem.org/mediawiki/2013/f/f8/2013ustc-china_T-VACCINE.png" width="100%" height="123" />
         <div id="tlogo"><img src="https://static.igem.org/mediawiki/2013/f/f8/2013ustc-china_T-VACCINE.png" width="100%" height="123" />
         </div>
         </div>
Line 60: Line 60:
<div class="conbar2">
<div class="conbar2">
<div class="leftbar" align="left">
<div class="leftbar" align="left">
-
         <div class="bassic-bar">
+
         <div class="basic-bar">
-
        According to our experiment result, we have proved the secretion and expression possibility of TD1-antigen, TD1-adjuvant, also the antigenicity of TD1-antigen after transdermal process. So in the following experiments, we decided to utilize Bacillus Subtillis WB800N as engineering bacteria, plus shuttle vector pHT43 as secretion vector to build the Bacillus Subtillis secretory expression system. On top of this, we have taken advantage of different kinds of TD1-antigen, testing HBsAg, PA, Ag85b that have been applied into market to check the universal property of TD1-antigen. Besides, reporters that are essential during reality application have been found to make the final circuit come true.
+
  <h1>Introduction<h1>
-
        </div>
+
    <p>According to our experiment result, we have proved the secretion and expression possibility of TD1-antigen, TD1-adjuvant, also the antigenicity of TD1-antigen after transdermal process. So in the following experiments, we decided to utilize Bacillus Subtillis WB800N as engineering bacteria, plus shuttle vector pHT43 as secretion vector to build the Bacillus Subtillis secretory expression system. On top of this, we have taken advantage of different kinds of TD1-antigen, testing HBsAg, PA, Ag85b that have been applied into market to check the universal property of TD1-antigen. Besides, reporters that are essential during reality application have been found to make the final circuit come true.<p>
Line 69: Line 69:
<div><p>In order to realize the secretory expression in Bacillus Subtillis, we inserted signal peptide between promoter and the TD1-Antigen/adjuvant sequence to secrete our recombinant protein. GFP has been chosen to check whether the reliability of this circuit. After large amounts of experiments, GFP has finally been found via fluorescence microscope. </p></div>
<div><p>In order to realize the secretory expression in Bacillus Subtillis, we inserted signal peptide between promoter and the TD1-Antigen/adjuvant sequence to secrete our recombinant protein. GFP has been chosen to check whether the reliability of this circuit. After large amounts of experiments, GFP has finally been found via fluorescence microscope. </p></div>
<img src="https://static.igem.org/mediawiki/igem.org/2/2a/2013ustc-china_WB800Nxianlu.png"width="400" height="150" />
<img src="https://static.igem.org/mediawiki/igem.org/2/2a/2013ustc-china_WB800Nxianlu.png"width="400" height="150" />
-
</div>
+
 
<div><p>Then, three kinds of recombinant antigen, TD1-HBsAg, TD1-PA, TD1-Ag85b, and recombinant immunologic adjuvant were designed. The earliest successful one TD1-LTB protein, can not only be observed clear stripes in SDS-PAGE, but also be proved according to HPLC-MS.</p></div>
<div><p>Then, three kinds of recombinant antigen, TD1-HBsAg, TD1-PA, TD1-Ag85b, and recombinant immunologic adjuvant were designed. The earliest successful one TD1-LTB protein, can not only be observed clear stripes in SDS-PAGE, but also be proved according to HPLC-MS.</p></div>
 +
<img src="https://static.igem.org/mediawiki/igem.org/a/ac/2013ustc-china_wb800N_gfp_jiaotu.png">
 +
</div>
 +
</div>
<div class="rightbar">
<div class="rightbar">
<div class="port-sidebar-border"><h>Project</h></div>
<div class="port-sidebar-border"><h>Project</h></div>
Line 79: Line 82:
<div id="t2"><a href="https://2013.igem.org/Team:USTC_CHINA/Project/ProjectDetails/Design">Design</a></div>
<div id="t2"><a href="https://2013.igem.org/Team:USTC_CHINA/Project/ProjectDetails/Design">Design</a></div>
<div id="t1"><a class="active" href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">Results</a></div>
<div id="t1"><a class="active" href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">Results</a></div>
-
<div id="t2"><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">Bassic Experiment</a></div>
+
<div id="t2"><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">Basic Experiment</a></div>
-
<div id="t2"><a class="active" href="https://2013.igem.org/Team:USTC_CHINA/Project/Results/FurthurWork">Furthur Work</a></div>
+
<div id="t2"><a class="active" href="https://2013.igem.org/Team:USTC_CHINA/Project/Results/FurtherWork">Further Work</a></div>
-
<div id="t1"><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Parts">Parts</a></div>
+
<div id="t1"><a href="https://2013.igem.org/Team:USTC_CHINA/Parts">Parts</a></div>

Latest revision as of 09:29, 27 September 2013

Introduction

According to our experiment result, we have proved the secretion and expression possibility of TD1-antigen, TD1-adjuvant, also the antigenicity of TD1-antigen after transdermal process. So in the following experiments, we decided to utilize Bacillus Subtillis WB800N as engineering bacteria, plus shuttle vector pHT43 as secretion vector to build the Bacillus Subtillis secretory expression system. On top of this, we have taken advantage of different kinds of TD1-antigen, testing HBsAg, PA, Ag85b that have been applied into market to check the universal property of TD1-antigen. Besides, reporters that are essential during reality application have been found to make the final circuit come true.

① Expression of antigen/adjuvant in Bacillus Subtillis

In order to realize the secretory expression in Bacillus Subtillis, we inserted signal peptide between promoter and the TD1-Antigen/adjuvant sequence to secrete our recombinant protein. GFP has been chosen to check whether the reliability of this circuit. After large amounts of experiments, GFP has finally been found via fluorescence microscope.

Then, three kinds of recombinant antigen, TD1-HBsAg, TD1-PA, TD1-Ag85b, and recombinant immunologic adjuvant were designed. The earliest successful one TD1-LTB protein, can not only be observed clear stripes in SDS-PAGE, but also be proved according to HPLC-MS.